SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-216725
Filing Date
2011-08-09
Accepted
2011-08-09 17:11:55
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 567153
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8529
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8499
4 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 4745
  Complete submission text file 0001193125-11-216725.txt   2683561

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sgnt-20110630.xml EX-101.INS 431725
6 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20110630.xsd EX-101.SCH 13268
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20110630_cal.xml EX-101.CAL 37643
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20110630_def.xml EX-101.DEF 25758
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20110630_lab.xml EX-101.LAB 130869
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20110630_pre.xml EX-101.PRE 86805
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35144 | Film No.: 111021821
SIC: 2834 Pharmaceutical Preparations